Events

(Webinar) After the Ice Bucket Challenge: Where Does the ALS Money Go?

Event

Join Dr. Merit Cudkowicz, Chief of Neurology at Massachusetts General Hospital, on December 2 for an informative and interactive discussion on what's next for ALS - including current treatment options and future R&D prospects. The complimentary webinar is presented by DrugDev. Join the Conversation.

Market Developments in Diabetes: Current and Future Treatment Trends in Major and Pharmerging Markets

Event

Dec 2, 2014 - 3.00pm GMT / 10.00am EST. This IMS Health webinar investigates the key market drivers for drug developers active in this lucrative market, and those looking to enter it, analyzing the most important factors that will determine how the market develops over the next 10 years. Speakers: Christine Henry, Ph.D., Senior Analyst, CV & Metabolic Diseases, and Donny Wong, Ph.D., Director, IMS Disease Insights. Register here.

Drug Development Primer

Event | December 4-5 | Boston, MA

This intensive two-day course will concentrate on the regulatory, commercial and scientific considerations required to successfully bring a drug to market. View Agenda and Register today!

FierceBiotech presents: Executive Breakfast at the J.P. Morgan Healthcare Conference

Event | January 13, 2015 | San Francisco, CA

By all accounts, biotech assets have never been worth more. What does 2015 hold in store for the biotech industry? Join FierceBiotech Editor-in-Chief John Carroll and a panel of industry experts as they discuss this and more at an executive breakfast in San Francisco, CA. Register Today!

2015 European Pharma CI Conference

Event | February 24-25, 2015 | Amsterdam, Netherlands

The European Pharma CI Conference is the premier gathering of senior level pharmaceutical, biotechnology, medical device, and diagnostics executives in competitive intelligence in Europe. For more info go to http://pharmaciconference.com/ or email info@pharmaciconference.com or call +1-212-228-7974.

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Event

This new report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. It will cover the following principle therapies; checkpoint inhibitors, anticancer vaccines, and adoptive cellular immunotherapy. For more info, visit: www.InsightPharmaReports.com.